Vanguard Fiduciary Trust
CTOR

Vanguard Fiduciary Trust’s Citius Oncology CTOR Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.2K Hold
121,910
– – ﹤0.01% 3780
2026
Q1 		$75.6K Buy
+121,910
New +$122K ﹤0.01% 3759

Other funds holding CTOR

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Vanguard Fiduciary Trust's CTOR Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Citius Oncology (CTOR) position steady in Q2 2026 at 121,910 shares worth $79.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3780.

Vanguard Fiduciary Trust first reported a position in CTOR in Q1 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold CTOR as of Q2 2026.

  • Vanguard Fiduciary Trust held 121,910 shares of Citius Oncology worth $79.2K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Citius Oncology share count unchanged in Q2 2026.
  • Citius Oncology made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3780 holding.
  • Vanguard Fiduciary Trust first reported a position in Citius Oncology in Q1 2026 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.